Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Hemostasis Diagnostics Market to reach USD 12.40 million by the end of 2030.

Global Hemostasis Diagnostics Market Size study & Forecast, by Product (Laboratory Analyzers, Point-of-Care Testing Systems), by Test Type (Activated Partial Thromboplastin Time, D Dimer Test, Fibrinogen Test, Prothrombin Time Test, Activated Clotting Time, Platelet Aggregation Test), by End Use (Hospitals, Diagnostic Centers, Others) and Regional Analysis, 2023-2030

Product Code: HLSMD-41449829
Publish Date: 20-07-2023
Page: 200

Global Hemostasis Diagnostics Market is valued approximately USD 6.41 million in 2022 and is anticipated to grow with a healthy growth rate of more than 8.60% over the forecast period 2023-2030. Hemostasis diagnostic devices help discover hemostatic disorders that cause excessive bleeding. During hemostasis, blood transforms from liquid to gelatinous. Hemostasis is a technique that the body uses after an injury to limit blood loss and cease blood flow. Following this, there are three further steps: vasoconstriction, platelet plug formation, and blood coagulation. Rising blood clotting diagnostic rates among patients, particularly those who are more prone to losing extra blood from the body after procedures, are important reasons driving market expansion. The growth in the incidence of many diseases such as cancer, diabetes, and neurological disorders, as well as the increase in the older population and lifestyle changes, drive the hemostasis diagnostics market. During the projected period, the worldwide hemostasis diagnostics market is expected to be driven by an increase in the prevalence of haemophilia.

Rising incidents of blood clotting disorders, technical developments in medical treatment, and increased acceptance of automated hemostasis equipment are all having an impact on the growth of the market under consideration. According to the World Bleeding Disorders Registry 2021 report, a survey of 37 countries reported 9,414 people with haemophilia as of December 2021, with South-East Asia having the highest prevalence with 2,828 affected individuals, followed by the Eastern Mediterranean and Africa with 2,418 and 1,027 affected individuals, respectively. Additionally, growing continuous advancement in research and development initiatives to miniaturize molecular and professional diagnostic testing is anticipated to create the lucrative opportunity for the market during forecast period. However, a lack of awareness about hemostasis diseases in developing regions, in addition to stringent government regulations, might hinder the market growth throughout the forecast period of 2023-2030

The key regions considered for the Global Hemostasis Diagnostics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the widespread use of powerful automated analyzers, the availability of a large patient pool, and the high frequency of blood clot illnesses, and supportive government initiatives. Asia Pacific is expected to grow significantly during the forecast period, the region’s rapid market rise can be ascribed to several government efforts aimed at improving health-care infrastructure. The market in the area is expected to grow significantly in comparison to other regions, owing to a change in the base of pharmaceutical businesses and clinical research industries from developed to emerging nations such as China and India.

Major market player included in this report are:
Thermo Fisher Scientific Inc.
HORIBA Europe Holding
Technidyne Corporation
Grifols S.A
F. Hoffmann-La Roche Ltd.
Haemonetics Corporation
Beckman Coulter Inc.
Recent Developments in the Market:
Ø In December 2022, the US FDA granted HemoSonics’ Quantra Hemostasis System with QStat Cartridge 510(k) commercial approval The QStat Cartridge test, according to the manufacturer, expands Quantra’s total diagnostic capabilities. The newest point-of-care hemostasis analyzer in the United States, the next-generation whole-blood hemostasis system, covers the broadest range of clinical purposes.
Ø In November 2022, a Dutch company, Enzyre, which is developing ambulant diagnostic technology for blood coagulation testing, successfully raised USD 11.9 million (EUR 12 million) in series A funding to help hemophilia patients test from home

Global Hemostasis Diagnostics Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Product, Test Type, End Use, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Laboratory Analyzers
Point-of-Care Testing Systems
By Test Type:
Activated Partial Thromboplastin Time
D Dimer Test
Fibrinogen Test
Prothrombin Time Test
Activated Clotting Time
Platelet Aggregation Test
By End Use:
Diagnostic Centers

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Hemostasis Diagnostics Market, by Region, 2020-2030 (USD Million)
1.2.2. Hemostasis Diagnostics Market, by Product, 2020-2030 (USD Million)
1.2.3. Hemostasis Diagnostics Market, by Test Type, 2020-2030 (USD Million)
1.2.4. Hemostasis Diagnostics Market, by End Use, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Hemostasis Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Hemostasis Diagnostics Market Dynamics
3.1. Hemostasis Diagnostics Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Rising Incidences of Blood Clotting Disorders Rising Adoption of Automated Hemostasis Equipment
3.1.2. Market Challenges Stringent Government Regulation
3.1.3. Market Opportunities Advancements in R&D
Chapter 4. Global Hemostasis Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Hemostasis Diagnostics Market, by Product
5.1. Market Snapshot
5.2. Global Hemostasis Diagnostics Market by Product, Performance – Potential Analysis
5.3. Global Hemostasis Diagnostics Market Estimates & Forecasts by Product 2020-2030 (USD Million)
5.4. Hemostasis Diagnostics Market, Sub Segment Analysis
5.4.1. Laboratory Analyzers
5.4.2. Point-of-Care Testing Systems
Chapter 6. Global Hemostasis Diagnostics Market, by Test Type
6.1. Market Snapshot
6.2. Global Hemostasis Diagnostics Market by Test Type, Performance – Potential Analysis
6.3. Global Hemostasis Diagnostics Market Estimates & Forecasts by Test Type 2020-2030 (USD Million)
6.4. Hemostasis Diagnostics Market, Sub Segment Analysis
6.4.1. Activated Partial Thromboplastin Time
6.4.2. D Dimer Test
6.4.3. Fibrinogen Test
6.4.4. Prothrombin Time Test
6.4.5. Activated Clotting Time
6.4.6. Platelet Aggregation Test
Chapter 7. Global Hemostasis Diagnostics Market, by End Use
7.1. Market Snapshot
7.2. Global Hemostasis Diagnostics Market by End Use, Performance – Potential Analysis
7.3. Global Hemostasis Diagnostics Market Estimates & Forecasts by End Use 2020-2030 (USD Million)
7.4. Hemostasis Diagnostics Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Diagnostic Centers
7.4.3. Others
Chapter 8. Global Hemostasis Diagnostics Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Hemostasis Diagnostics Market, Regional Market Snapshot
8.4. North America Hemostasis Diagnostics Market
8.4.1. U.S. Hemostasis Diagnostics Market Product breakdown estimates & forecasts, 2020-2030 Test Type breakdown estimates & forecasts, 2020-2030 End Use breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Hemostasis Diagnostics Market
8.5. Europe Hemostasis Diagnostics Market Snapshot
8.5.1. U.K. Hemostasis Diagnostics Market
8.5.2. Germany Hemostasis Diagnostics Market
8.5.3. France Hemostasis Diagnostics Market
8.5.4. Spain Hemostasis Diagnostics Market
8.5.5. Italy Hemostasis Diagnostics Market
8.5.6. Rest of Europe Hemostasis Diagnostics Market
8.6. Asia-Pacific Hemostasis Diagnostics Market Snapshot
8.6.1. China Hemostasis Diagnostics Market
8.6.2. India Hemostasis Diagnostics Market
8.6.3. Japan Hemostasis Diagnostics Market
8.6.4. Australia Hemostasis Diagnostics Market
8.6.5. South Korea Hemostasis Diagnostics Market
8.6.6. Rest of Asia Pacific Hemostasis Diagnostics Market
8.7. Latin America Hemostasis Diagnostics Market Snapshot
8.7.1. Brazil Hemostasis Diagnostics Market
8.7.2. Mexico Hemostasis Diagnostics Market
8.8. Middle East & Africa Hemostasis Diagnostics Market
8.8.1. Saudi Arabia Hemostasis Diagnostics Market
8.8.2. South Africa Hemostasis Diagnostics Market
8.8.3. Rest of Middle East & Africa Hemostasis Diagnostics Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Abbott Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
9.3.2. Thermo Fisher Scientific Inc.
9.3.3. HORIBA Europe Holding
9.3.4. Medtronic
9.3.5. Technidyne Corporation
9.3.6. Grifols S.A
9.3.7. F. Hoffmann-La Roche Ltd.
9.3.9. Haemonetics Corporation
9.3.10. Beckman Coulter Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now